Sirolimus Stent (LYNX)

Highlighting Features

• Lynx is first indigenously developed Drug Eluting Stent in India.
• The Strut Thickness for Lynx is 65 μm
• Unique Open and closed Cells Stent Design on L 605 Cobalt Chromium Stent platform with Strut locking mechanism.  This offers excellent radial strength and minimum recoil
• Improved Stent apposition and Uniform neointimal coverage
• Inhibits in-stent restenosis (ISR) and late thrombosis with adequate Re- Endothelialization
• Completely biodegradable, Biocompatible polymer (PLA carrier) – Loading density of 1.2 μg/mm²
• 3 μm – Uniform coating thickness with precisely programmed release kinetics
• Designed for utmost safety – Lynx displays one of the lowest entry profile.
• Hydrophilic Coated Stent Delivery System
• 90% of Sirolimus is released within 90-120 days